Section 721.5550 - Substituted dialkyl oxazolone (generic name)(a)Chemical substances and significant new uses subject to reporting.(1) The chemical substance identified generically as substituted dialkyl oxazolone (PMN P-86-1634) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.(2) The significant new uses are: (i)Protection in the workplace. Requirements as specified in § 721.63 (a)(1), (a)(3), (a)(4), (a)(5)(xi), (a)(6)(v), (b) (concentration set at 0.1 percent), and (c).(ii)Hazard communication program. Requirements as specified in § 721.72 (a), (b)(2), (c), (d), (e) (concentration set at 0.1 percent), (f), (g)(1)(iii), (g)(1)(vi), (g)(1)(vii), (g)(1)(ix), (g)(2)(i), (g)(2)(ii), (g)(2)(iv), and (g)(2)(v).(iii)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(q) .(iv)Disposal. Requirements as specified in § 721.85 (a)(1), (a)(2), (b)(1), (b)(2), (c)(1), and (c)(2) .(b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.(1)Recordkeeping. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in § 721.125 (a) through (j) .(2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.(3)Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to this section.55 FR 33306, Aug. 15, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993